1504 studies found for:    EGFR
Show Display Options
Rank Status Study
1 Unknown  Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
Condition: NSCLC
Intervention: Other: cancer cell lines establishment
2 Completed Laryngeal and Esophageal EGF-r Expression in Patients With Reflux Laryngitis
Conditions: Gastroesophageal Reflux Disease (GERD);   Chronic Laryngitis
Interventions: Procedure: Biopsy of the retrocrycoid laryngeal mucosa;   Procedure: Biopsy of the distal esophageal mucosa
3 Recruiting Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)
Condition: Advanced EGFR-positive Solid Tumors
Intervention: Biological: CART-EGFR
4 Recruiting A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF
Condition: Plaque Psoriasis
Interventions: Drug: Human recombinant epidermal growth factor;   Other: Placebo cream
5 Recruiting Asia Pacific and Russia Diagnostic Study for EGFR Testing
Condition: EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.
Intervention: Genetic: EGFR mutation test
6 Recruiting Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma
Condition: Carcinoma, Squamous Cell
Intervention: Biological: EGFR Antisense DNA
7 Recruiting Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream Lotion, for EGFR'I Induced Acneiform Rash
Condition: Acneiform Rash
Interventions: Drug: Threolone ointment;   Drug: ointment Synthomycine;   Drug: Aqua cream lotion
8 Active, not recruiting Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients
Condition: Metastatic Non-Small-Cell Lung Cancer
Intervention:
9 Enrolling by invitation Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC
Condition: Lung Neoplasms
Intervention:
10 Recruiting Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
Condition: EGFR Mutation Positive Non-small Cell Lung Cancer
Intervention: Drug: EGFR TKIs (gefitinib, erlotinib, afatinib, et al)
11 Completed Europe-Japan Diagnostic Study for EGFR Testing
Condition: EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.
Intervention:
12 Active, not recruiting Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash
Condition: EGFR Inhibitor-associated Rash
Intervention: Drug: Menadione Topical Lotion
13 Unknown  First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
Conditions: Lung Neoplasms;   Non-Small Cell Lung Cancer;   Adenocarcinoma, Bronchiolo-Alveolar
Intervention: Drug: Erlotinib
14 Enrolling by invitation Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma
Condition: Cancer
Interventions: Drug: TCM;   Drug: EGFR-TKI
15 Active, not recruiting Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria
Conditions: Diabetes;   Hypertensive Disease
Interventions: Drug: Renin-angiotensin system blockers;   Drug: non-renin angiotensin system blockers
16 Completed
Has Results
Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors
Condition: Skin Toxicities
Intervention: Other: Questionnaire
17 Recruiting Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc
Condition: Advanced Stage Non Small Cell Lung Cancer
Interventions: Drug: Erlotinib 100mg qd;   Drug: Gefitinib 250mg qd
18 Completed Anti-EGFR Immunoliposomes in Solid Tumors
Condition: Solid Tumors
Intervention: Drug: anti-EGFR immunoliposomes loaded with doxorubicin
19 Completed A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology
Condition: Non-Small Cell Lung Cancer
Intervention:
20 Recruiting Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Condition: Non Small Cell Lung Cancer
Interventions: Procedure: Stereostatic Radiosurgery;   Drug: Erlotinib

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years